Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-12022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-08 |
filingDate |
1993-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1997-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f845e96ee788bf40d24003782a0fa37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb4219e74ae15752ea5a313821248444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6721706a13245b53ae309903a90e454f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_779fa9f0c6afe85fd6d8b0628587f1de |
publicationDate |
1997-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5625049-A |
titleOfInvention |
Nucleic acids encoding human astrovirus serotype 2 |
abstract |
The present invention provides a nucleic acid encoding human Astrovirus serotype 2, or a unique fragment thereof. The sequence, a genomic RNA of human astrovirus serotype 2 contains 6,797 nucleotides, and is organized into three open reading frames. Also provided are purified antigenic polypeptide fragments encoded by the nucleic acid encoding human Astrovirus serotype 2, or unique portions thereof. The present invention also provides a monoclonal antibody specific for human astrovirus serotype 2 and isolated nucleic acids capable of selectively hybridizing with the nucleic acid of serotype 2, including methods for detecting the presence of serotype 2 utilizing these products. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011022503-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03014397-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6696562-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614090-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011045018-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7381524-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6649356-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005079485-A1 |
priorityDate |
1993-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |